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strated that HGF directly stimulated c-met promoter trans-Up-regulation of hepatocyte growth factor receptor: An ampli-
activation in renal epithelial cells.fication and targeting mechanism for hepatocyte growth factor
Conclusion. These results suggest that local up-regulation ofaction in acute renal failure.
c-met transcription in the kidney is crucial to renal tubuleBackground. Hepatocyte growth factor (HGF) and its c-met
repair and regeneration, not only because it increases overallreceptor comprise a signaling system that has been implicated
activity of this receptor–ligand system, but also as a mechanismin tissue repair and regeneration. HGF action is specifically
targeting HGF action specifically to renal epithelia.targeted to the damaged organ following injury; however, the
mechanism underlying this important targeting process re-
mains to be elucidated. We reasoned that induction of c-met
expression might be a critical factor in determining the site
Hepatocyte growth factor (HGF) is a pleiotropic pro-specificity of this receptor–ligand system. To test this hypothe-
tein originally isolated as a potent mitogen for hepato-sis, we examined changes in activity of the HGF/c-met system
in the folic acid model of acute tubular injury and repair. cytes. The receptor for HGF is c-met, the product of
Methods. Tissue HGF and c-met mRNA levels were de- c-met proto-oncogene belonging to tyrosine kinase re-
tected by RNase protection assay and Northern blot analysis ceptor superfamily [1]. This signaling system acts on afollowing acute renal injury induced by a single injection of folic
wide spectrum of cellular targets in multiple ways [2–4].acid. HGF and c-met proteins were examined by a specific
In addition to its mitogenic action [5], HGF promotesenzyme immunoassay and Western blotting, respectively. C-met
expression and trans-activation were investigated by exposing cell motility, acting as a scatter factor to stimulate the
renal epithelial mIMCD-3 cells to various cytokines in vitro. dispersion and migration of cultured epithelial cells [6, 7].
Results. Extremely rapid induction of renal HGF and c-met
Moreover, HGF has unique morphogenic actions, induc-mRNA was observed beginning one hour following injection
ing several types of epithelial cells to form branchingof folic acid. Circulating plasma HGF protein level rose dramat-
ically (approximately 16-fold), peaking first at two hours and tubule-like structures in vitro [8, 9]. The HGF/c-met sys-
again at 24 hours following injection. Despite elevated HGF tem plays an essential role in organ development, as null
mRNA in the kidney, total kidney HGF protein actually de- mutations of either HGF or c-met gene result in lethalcreased significantly at 24 hours following injury. On the other
phenotypes characterized by marked abnormalities inhand, both c-met mRNA and c-met protein were markedly
the liver and placenta [10–12]. Studies in vivo suggestincreased in the kidney, where active renal tubule repair and
regeneration take place. In vitro studies suggested that in- that HGF/c-met also plays a pivotal role in promoting
creased levels of HGF, as well as other cytokines, might account tissue regeneration of injured organs [13–15].
for enhanced c-met expression in renal tubular epithelial cells.
In the kidney, HGF and its c-met receptor have beenPretreatment of the cells with actinomycin D totally blocked c-
implicated in the regulation of a variety of physiologicalmet induction, suggesting that induced c-met expression occurs
primarily at the transcriptional level. Using a cloned region of and pathophysiological processes, including renal devel-
the c-met promoter coupled to a reporter gene, we demon- opment [16–18], compensatory kidney growth, and tu-
bule repair and renal regeneration following acute injury
[19–22]. In fact, kidney is one of the organs in whichKey words: HGF, folic acid, tubule repair, c-met, renal epithelia,
receptor-ligand system. c-met is most highly expressed both during development
as well as in adult animals [23–25]. Kidney HGF and c-metReceived for publication March 24, 1998
mRNA levels increase significantly in animals followingand in revised form August 10, 1998
Accepted for publication August 31, 1998 acute injury induced by ischemia or administration of
a nephrotoxin [19, 21]. Urinary HGF excretion is also 1999 by the International Society of Nephrology
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elevated in patients with acute renal failure [26]. More- 1, 3, 6, 12, 24, and 48 hours postinjection, respectively.
For measurement of DNA synthesis, folic acid–treatedover, administration of exogenous HGF ameliorates
and control rats received an injection (50 mg/kg bodyacute renal failure (ARF) and accelerates renal regener-
weight, i.p.) of 5-bromo-29-deoxyuridine (BrdU; Sigma)ation in both murine and rodent models of ARF [14, 15].
one hour prior to sacrifice. One kidney of each rat wasDespite compelling evidence demonstrating the thera-
processed for tissue histology and immunohistochemis-peutic potential of HGF in acute renal injury, important
try. The other kidney from each animal was immediatelyaspects of the response are poorly understood. For exam-
frozen in liquid nitrogen and was stored at 2808C forple, following nephrectomy or an ischemic insult, HGF
subsequent RNA extraction and tissue lysate preparation.expression is markedly augmented not only in the kid-
neys but also in distant organs such as liver [21]. Simi-
Measurement of serum creatininelarly, after partial hepatectomy or carbon tetrachloride
Tail vein blood was obtained for measurement of se-administration, HGF mRNA levels are increased not
rum creatinine. Creatinine was measured by establishedonly in the liver, but in other organs as well [27]. Simulta-
methods using an autoanalyzer [30].neous increases in HGF gene expression in multiple or-
gans are potentially advantageous by providing abundant RNA isolation and RNase protection assay
HGF in an endocrine fashion to the damaged organ, but
Total RNA was extracted from the rat kidney andonly if proliferative responses in undamaged tissues are
other organs by a single-step method using an Ul-avoided. Currently, the mechanism by which the sys-
traspece RNA isolation system according to the instruc-temic HGF response is targeted specifically to the injured
tions specified by the manufacturer (Biotecx Labora-organ is poorly understood.
tories Inc., Houston, TX, USA). RNA was quantitatedAlthough HGF elicits diverse biological actions in a
by determination of ultraviolet absorbance at 260 nm.wide variety of target cells, evidence suggests that all
RNA purity was assessed by measuring the optical den-of these responses are mediated by a single functional
sity ratio at 260 and 280 nm. The RNase protection assayreceptor, c-met [1, 28]. Logically, alterations in c-met
was performed using a high-speed hybridization ribo-receptor abundance and activity might be an important
nuclease protection assay kit (HybSpeede RPA; Am-site of regulation for the HGF/c-met signaling system.
bion Inc., Austin, TX, USA). For generating antisenseWe hypothesized that increased production of c-met not
RNA probes, a rat c-met cDNA fragment of 262 bponly regulates the extent, but also determines the site of
(nucleotides 723–984) [25] was cloned into the EcoRI
cell proliferation and tissue regeneration. To investigate restriction site of the pBluescript II SK vector (Stra-
this possibility, we studied c-met receptor and HGF tagene, La Jolla, CA, USA). Likewise, a rat HGF cDNA
mRNA and protein expression in the rat kidney in a fragment of 265 bp (nucleotides 709–975) was also cloned
model of acute tubular injury induced by injection of into the same plasmid vector. Control b-actin plasmid
folic acid. We found marked increases in circulating HGF (pTR-b-Actin-Mouse) containing 250 bp of sequence
levels and in kidney c-met mRNA and protein levels complementary to the mouse b-actin gene was provided
following administration of folic acid. Studies in cultured in the kit (Ambion). Antisense RNA probes were syn-
cells revealed that HGF, as well as several other cyto- thesized from the linearized plasmids, using MAXI-
kines and growth factors, induces c-met expression in scripte in vitro transcription kit (Ambion) with 32P-UTP
renal epithelial cells. Our data suggest that increased (Amersham Life Science, Inc., Arlington Heights, IL,
c-met expression may be a crucial factor determining USA) and T3 RNA polymerase. Fifty micrograms of
site specificity of HGF/c-met signaling in acute tissue total RNA isolated from rat kidney or control yeast were
injury. denatured at 1008C for two minutes and were hybridized
with the radioactive antisense probes (5 3 104 cpm).
After incubation at 688C for 10 minutes with hybridiza-METHODS
tion buffer, the reaction mixture was incubated at 378C
Animals and folic acid model with a mixture of RNase T1 and RNase A for 30 minutes.
Male Sprague-Dawley rats (200 to 220 g) were pur- The antisense RNA probes that were hybridized with c-
chased from Taconic Farms (Germantown, NY, USA). met, HGF, or b-actin mRNA formed a double-stranded
They were housed in the Central Research Facilities of structure and were protected from RNase digestion. The
the Rhode Island Hospital and were fed standard rat final product was precipitated with ethanol and resolved
chow and water ad libitum. Acute renal injury was in- on a 6% acrylamide DNA sequencing gel containing 8
duced by a single i.p. injection of folic acid (Sigma, St. m urea.
Louis, MO, USA) at 250 mg/kg body weight in 150 mm
Northern blot analysissodium bicarbonate (vehicle), as described previously
[29]. The same volume of vehicle was injected into the Northern blot analysis for gene expression was carried
out by published procedures [31]. Briefly, samples of 20control rats. Six rats from each group were sacrificed at
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mg total RNA were electrophoresed on 1.0% formalde- recovered for determination of HGF using the rat HGF
EIA kit as described earlier here. The protein concentra-hyde-agarose gels and were then transferred to Gene-
Screen plus nylon membrane (Dupont, Boston, MA, tion of the supernatant was determined using a protein
assay kit (Sigma). The concentration of HGF in tissuesUSA) by capillary blotting. Membranes were prehybrid-
ized for four hours at 658C in a buffer containing 6 3 was expressed as nanograms per milligram protein.
SSC (20 3 SSC equals 3 m NaCl and 0.3 m sodium citrate,
Western blot analysispH 7.0), 5 3 Denhardt’s solution (0.1% Ficoll-400, 0.1%
polyvinylpyrrolidone, 0.1% bovine serum albumin), 1% Kidneys and other organs from either control or folic
acid–treated rats were homogenized in RIPA lysis buffersodium dodecyl sulfate (SDS), 10% dextran sulfate, and
100 mg/ml denatured salmon sperm DNA. 32P-labeled (1% NP40, 0.1% SDS, 100 mg/ml phenylmethylsulfonyl-
fluoride, 0.5% sodium deoxycholate, 1 mm sodium ortho-DNA probes were prepared by the random primer label-
ing kit (Stratagene) using [a-32P]dCTP, as described pre- vanadate, 2 mg/ml aprotinin, 2 mg/ml antipain, and 2 mg/
ml leupeptin in phosphate-buffered saline) on ice, andviously [25]. Denatured probes were added to the same
hybridization buffer at a concentration of 1 to 2 3 106 the supernatants were collected after centrifugation at
13,000 3 g at 48C for 20 minutes. Protein concentrationcpm/ml, and hybridization was allowed to proceed at
658C for 16 hours. Membranes were washed twice in 2 3 was determined using a protein assay kit (Sigma), and
tissue lysates were mixed with an equal amount 2 3SSC-0.2% SDS at room temperature for 10 minutes,
followed by two washes in 0.1 3 SSC-0.2% SDS at 658C loading buffer (100 mm Tris-HCl, 4% SDS, 20% glycerol,
and 0.2% bromophenol blue). Samples were separatedfor 20 minutes. The membranes were then exposed to
x-ray film at 2808C with the aid of an intensifying screen. on an 10% SDS-polyacrylamide gel under nonreducing
conditions. The proteins were electrotransferred to aAfter autoradiography, membranes were stripped and
rehybridized with rat glyceraldehyde-3-phosphate dehy- polyvinylidene difluoride membrane (Hybond-P; Amer-
sham) in transfer buffer containing 48 mm Tris-HCl, 39drogenase probe to assure equal loading of each lane.
The intensity of the hybridization signals was scanned mm glycine, and 20% methanol at 48C for one hour.
Nonspecific binding to the membrane was blocked forand analyzed on a SUN SPARC station using Quantity
One analysis software (Huntington Station, NY, USA). one hour at room temperature with 5% Carnation nonfat
milk in TBS buffer (20 mm Tris-HCl, pH 7.5, 150 mm
Determination of HGF protein NaCl, and 0.1% Tween 20). The membrane was then
incubated at 48C for 16 hours with an affinity-purifiedThe amount of rat plasma HGF was measured using
a commercial enzyme immunoassay (EIA) kit purchased polyclonal rabbit IgG raised against the synthetic peptide
corresponding to the C-terminal amino acids of mousefrom the Institute of Immunology (Tokyo, Japan). The
kit uses a sandwich method consisting of three steps of c-met protein (SP260; Santa Cruz Biochemicals, Santa
Cruz, CA, USA), followed by incubation for one hourantigen-antibody reactions. Briefly, a mouse antirat HGF
monoclonal antibody was coated onto 96-well microtiter with a goat antirabbit IgG horseradish peroxidase conju-
gate (Bio-Rad, Hercules, CA, USA) in 1% nonfat milk.plates. Fifty microliter aliquots of standard rat HGF solu-
tion or plasma samples were added to the wells and The signals were visualized by the enhanced chemilumi-
nescence system (Amersham).were incubated for 18 hours at room temperature. After
extensive washing, a 100 ml aliquot of rabbit antirat HGF
Assessment of DNA synthesis by BrdU labelingpolyclonal antibody was added, and the plates were incu-
bated for another two hours. They were then incubated DNA synthesis in kidney tissues was assessed by im-
munohistochemical staining of BrdU-labeled kidneys aswith peroxidase-labeled goat antirabbit IgG for an addi-
tional two hours, followed by incubation with enzyme described previously [22] except that an anti-BrdU
monoclonal antibody (Boehringer Mannheim Corp., In-substrate solution. The plates were allowed to stand for
30 minutes at room temperature, and the reaction was dianapolis, IN, USA) was used. Kidney tissue from con-
trol and folic acid–treated rats was fixed in neutral-buf-stopped by the addition of 50 ml 4 n H2SO4. Absorbance
was read at 490 nm by a Bio-Tek EL340 automatic mi- fered formalin for at least 24 hours, paraffin-embedded,
and sectioned at 5 mm thickness. Tissue sections on poly-croplate reader (Winooski, VT, USA).
For measurement of tissue HGF level, organs from l-lysine–plated glass slides were deparafinized and incu-
bated in 0.3% H2O2 in methanol for 30 minutes to blockcontrol and folic acid–treated rats were perfused with
saline in situ to remove blood prior to excision. Tissues endogenous peroxidase. Sections were then incubated
with the mouse anti-BrdU monoclonal antibody at 6were homogenized in the HGF extraction buffer con-
taining 20 mm Tris-HCl, pH 7.5, 2 m NaCl, 0.1% Tween- mg/ml for one hour at room temperature followed by
incubation with a secondary antibody (antimouse IgG-80, 1 mm ethylenediaminetetraacetic acid, and 1 mm
phenylmethylsulfonyl-fluoride. After centrifugation at peroxidase) for an additional hour. The slides were then
visualized by the addition of diaminobenzidine as sub-19,000 3 g for 30 minutes at 48C, the supernatant was
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strate and counterstained with hematoxylin. The slides the cells were washed twice with serum-free medium and
were extensively washed between each incubation period were incubated in serum-free medium for 24 hours in
with phosphate-buffered saline containing 0.05% Tween the presence or absence of 10 ng/ml of recombinant rat
20. Staining for BrdU was totally abrogated when the HGF. The cells were then harvested and disrupted by
primary antibody was omitted. The BrdU-positive cells three freeze–thaw cycles. The supernatant was assayed
were scored in at least five randomly selected fields under for CAT activity by the procedure described previously
a 320 objective. [34]. The reaction products were separated by thin layer
chromatography (Kodak, Rochester, NY, USA) and were
Cell culture procedures followed by autoradiography and liquid scintillation
Mouse inner medullary collecting duct epithelial cells counting. All experiments were repeated at least three
(mIMCD-3) developed from an SV40 transgenic mouse times to assure reproducibility. Relative CAT activity was
[32] were maintained in Dulbecco’s modified Eagle’s reported after normalization for b-galactosidase activity.
medium and Ham’s F-12 medium (1:1; Gibco-BRL,
StatisticsGrand Island, NY, USA) supplemented with 5% fetal
bovine serum (FBS). Opossum kidney cells derived from Animals were randomly assigned to control and treat-
opossum kidney proximal tubule were also maintained ment groups. For Northern blot analysis, RNase protec-
in the Dulbecco’s modified Eagle’s medium and Ham’s tion assay, and Western blot analysis, quantitation was
F-12 medium supplemented with 5% FBS. Cells were carried out by scanning and analyzing the intensity of the
seeded in plastic Petri dishes (100 mm; Falcon, Meylan, hybridization signals at the SUN SPARC station using
France) at 50% to 60% confluence and were incubated Quantity One analysis software. Statistical analysis of the
for 24 hours. Cells were serum-starved for 24 hours in data was performed by Student’s t-test using SigmaStat
the fresh medium containing 0.5% FBS before adding software (Jandel Scientific, San Rafael, CA, USA). A
cytokines. Purified recombinant rat HGF was prepared P value of less than 0.05 was considered significant.
as described previously [33]. Other cytokines were pur-
chased from R & D Systems (Minneapolis, MN, USA)
RESULTSand were reconstituted according to the manufacturer’s
suggestions. After a 24-hour incubation, the cells were Rapid induction of c-met and HGF mRNAs following
collected for isolation of total RNA and Northern blot acute renal injury in vivo
analysis for c-met expression as described earlier here.
Folic acid as administered in this study is a potentFor investigating the role of transcription in c-met induc-
nephrotoxic agent that causes acute structural and func-tion by HGF, cells were pretreated with 5 mg/ml actino-
tional abnormalities in renal tubules [29]. A single injec-mycin D for one hour to block transcription and were
tion of folic acid into rats caused serum creatinine tothen treated with or without HGF.
increase on average to 1.43 6 0.26 mg/dl at 24 hours
following injection, as compared with a mean value ofPlasmid construction, DNA transfection, and CAT assay
0.32 6 0.07 mg/dl in the control group (P , 0.01), whichChimeric human c-met promoter-reporter gene [chlor-
was indicative of severe acute renal failure. Folic acid-amphenicol acetyl transferase (CAT)] plasmid (p2.6met-
induced injury is reversible, and five days after injection,CAT) was constructed by cloning 2.6 kb of the 59-flanking
mean values for serum creatinine levels were similarsequence from the human c-met gene into the polylinker
in folic acid–treated and control rats (0.47 6 0.10 vs.region of the promoterless CAT-containing plasmid
0.33 6 0.14 mg/dl, P . 0.05). To examine the role ofpCAT3-Basic (Promega, Madison, WI, USA). The cor-
the HGF/c-met system in the renal repair process, werect orientation and the 59 and 39 boundaries of the
measured c-met mRNA levels in the kidneys of theseinsert of this plasmid were verified by detailed restriction
rats. C-met gene expression was assessed by RNase pro-mapping and nucleotide sequencing. For transient trans-
tection assay using rat c-met antisense RNA as a probe.fection, the mIMCD-3 cells were cultured in six-well
Shown in Figure 1, c-met mRNA was markedly increasedplates for 24 hours and were then transiently transfected
in the kidneys of folic acid–treated rats as compared withwith p2.6met-CAT plasmid using the DNA calcium phos-
control. Kinetic study revealed that c-met induction wasphate method [34] according to the instructions of the
present as early as one hour following injection (theCellPhect transfection kit (Pharmacia, NJ, USA). In each
earliest time point tested), was sustained at six hours,experiment, 1 3 105 mIMCD-3 cells were cotransfected
and had returned toward baseline levels at 12 hours.with 2.5 mg of the human c-met promoter-CAT chimeric
Determination of the level of c-met mRNA by scanningplasmid and 0.5 mg of the b-galactosidase reference plas-
densitometry revealed more than a fivefold increase inmid pCH110 (Pharmacia) as an internal standard for
c-met mRNA levels in the kidneys of folic acid rats astransfection efficiency. After incubation of the cells with
DNA-calcium phosphate coprecipitation for 16 hours, compared with control. This increase in the steady-state
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Fig. 2. DNA synthesis in renal tubular cells of rat kidneys following
injection of folic acid. The kidneys of folic acid–treated and untreated
rats were fixed at different time points as indicated. DNA synthesis
was assessed by immunohistochemistry using an anti-BrdU monoclonal
antibody. BrdU-labeled cells were counted from randomly selected
microscopic fields. ** P , 0.05 versus control group.
by folic acid, renal cell DNA synthesis was evaluated by
immunohistochemical staining for BrdU incorporation.Fig. 1. Induction of c-met and hepatocyte growth factor (HGF) expres-
sion in the rat kidney following injection of folic acid. Adult Sprague- As shown in Figure 2, very little DNA synthesis was
Dawley rats received a single i.p. injection of folic acid or vehicle. Total
evident in the kidneys of untreated rats as BrdU-labeledRNA was isolated from whole kidneys (pool of 6 animals per group)
of folic acid–treated or untreated rats at different time points as indi- cells were rarely found. In contrast, active DNA synthe-
cated. Fifty micrograms of total RNA was subjected to RNase protection sis was evident following injection of folic acid, as demon-
assay with antisense cRNA probes for rat c-met, rat HGF, and mouse
strated by a remarkable increase in the number of BrdU-b-actin, respectively (A, HGF probe; B, c-met probe; C, b-actin probe).
The sizes of RNase protection products are indicated on the right. positive cells, primarily in renal tubular epithelial cells.
The increase in the number of BrdU-positive cells began
at approximately 12 hours and peaked at 24 hours postin-
jection. Based on the kinetics of c-met and HGF genelevels of kidney c-met mRNA was confirmed by North-
induction described earlier here (Fig. 1), it is evident thatern hybridization analysis (data not shown).
the increase in c-met and HGF expression significantlyThe mRNA for HGF also increased in a concordant
precedes the increase in DNA synthesis in renal epithe-manner with the elevation in c-met transcripts (Fig. 1).
lial cells in folic acid–treated rats.Determination of the relative abundance of HGF mRNA
by scanning densitometry revealed an 11-fold induction
Circulating and kidney HGF protein levels
in the kidneys of rats given folic acid. This pattern of
Using a specific EIA assay for rat HGF, we found thatrapid and simultaneous induction of both c-met and
the circulating plasma HGF protein level rose rapidlyHGF suggests that marked activation of this signaling
and dramatically (16-fold) following folic acid adminis-system occurred, consistent with its proposed role in
tration (Fig. 3). In normal rats, a low but detectablepromoting the exuberant epithelial cell proliferation and
plasma level of HGF was found (approximately 1.0 ng/rapid tubule repair that are characteristic of this model.
ml). The rise in circulating plasma HGF protein began
Induction of c-met and HGF expression precedes as early as 0.5 hours, and peaked twice, first at two hours
renal epithelial cell proliferation and again at 24 hours after injection (Fig. 3). Although
the exact source of the plasma HGF is uncertain, evi-To investigate the relationship between the induction
of c-met/HGF expression and renal hyperplasia induced dence suggests that tissue injury initiates a protease cas-
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Fig. 3. Plasma HGF levels in rats following injection of folic acid.
Fig. 4. Kidney tissue HGF level following acute renal injury. KidneyPlasma was collected at the various time points as indicated. HGF levels
tissue from control or folic acid–treated rats was homogenized in HGFwere determined using an EIA kit specific for rat HGF. Data are
extraction buffer. HGF levels were determined using an EIA kit specificmean 6 se of six animals per group.
for rat HGF. Data are mean 6 se of six animals per group. **P , 0.01
versus control group.
cade causing degradation of extracellular matrix and
rapid release of matrix-bound HGF [35, 36]. Therefore,
acid injection, c-met protein level began to rise at sixmobilization of stored HGF may account for the first
hours and was markedly elevated at 24 hours postinjec-peak. The second HGF peak at 24 hours probably repre-
tion. Quantitation by scanning densitometry revealed asents newly synthesized protein released into the circula-
more than 60-fold increase in c-met protein at 24 hourstion from multiple sites.
in the kidneys of rats given folic acid as compared withSurprisingly, despite a marked increase in HGF
the control (Fig. 5B).mRNA in the kidney (Fig. 1), total HGF protein in the
kidney actually decreased significantly following acute
Induction of c-met, rather than HGF, correlates withrenal injury. At 24 hours after injection of folic acid,
renal injurykidney tissue HGF protein level was reduced to 55% of
We also measured the expression of HGF and c-metthat observed in control rats (Fig. 4). Of note, the method
in other organs following injection of folic acid. As shownthat we used measures total extractable HGF in the
in Figure 6, the steady-state level of HGF mRNA wastissue, which includes both cellular and extracellular ma-
increased in the lung at six hours and had returned totrix-bound HGF. Therefore, a decrease of total extract-
baseline at 24 hours after folic acid injection. However,able HGF protein may have occurred as a result of in-
no significant difference in c-met mRNA levels was ob-jury-associated release of stored, matrix-bound HGF to
served in the lung at various time points following injec-the circulation and/or active renal consumption follow-
tion (Fig. 6). A similar pattern of induction of HGFing injury.
expression without a parallel increase in c-met message
Kidney c-met protein levels in vivo was observed in other organs, including the liver and
spleen (data not shown).To investigate whether the elevated c-met mRNA in
Tissue HGF protein levels also increased in the lungthe kidneys results in increased c-met protein, we mea-
of the folic acid–injected rats (Fig. 7). A similar, but lesssured c-met protein in the kidney by Western blotting
marked, increase in tissue HGF protein was observed inusing a specific anti-c-met antibody. As shown in Figure
other organs of these rats, such as liver and spleen (Fig.5, renal total c-met protein increased following injection
7A). In contrast to the dramatic elevation of c-met pro-of folic acid. In kidneys from control rats, a modest
tein in the kidney (Fig. 5), little difference in c-met pro-amount of c-met protein was detected as a p190 protein
in a nonreducing SDS-polyacrylamide gel. After folic tein levels was observed in the nonrenal tissues, including
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Fig. 5. Induction of c-met receptor protein in the kidney following acute renal injury. Rat kidneys were isolated from folic acid–treated or
untreated rats at different time points as indicated. Kidney tissue lysates were prepared by homogenization in RIPA lysis buffer and were separated
on a nonreducing SDS-polyacrylamide gel (50 mg/lane). Immunoblotting was performed using a specific anti-c-met antibody (A, representative
Western blot gel; B, graphic presentation of c-met protein abundance). Quantitation of c-met protein levels was plotted after analyzing hybridized
signals by densitometer. Data are presented as means 6 se of six animals from each group and are expressed as arbitrary units. *P , 0.05; **P ,
0.01 versus control.
lung, liver, and spleen at various time points following
injection (Fig. 7B). As marked cell proliferation and
repair are limited to renal epithelial cells in this model,
these data suggest that induction of the c-met receptor,
rather than HGF itself, best correlates with the site of
tissue injury and regeneration.
Up-regulation of c-met expression in renal epithelial
cells in vitro
The finding of site-specific c-met induction in the kid-
neys of folic acid–treated rats prompted us to search for
factors that induce c-met expression in renal epithelial
cells. As activation of early response genes and growth
factors is a feature of the folic acid model of acute renal
failure [37, 38], we reasoned that the up-regulation of
renal c-met observed in vivo may be mediated by in-
creased availability of cytokines and growth factors in
this setting. Using an in vitro cell culture system, we dem-
onstrated that the steady-state level of the c-met transcript
was markedly increased over that of the untreated con-
Fig. 6. HGF and c-met expression in the rat lung following acute renal trol when renal epithelial cells were incubated in the pres-injury. Total RNA was isolated from the lungs (pool of six animals per
ence of several different cytokines and growth factorsgroup) of folic acid–treated or untreated rats at different time points
as indicated. Total RNA was subjected to Northern blot hybridization (Fig. 8). At a concentration of 10 ng/ml, cytokines inter-
using cDNA probes for rat HGF (A), rat c-met (B), and rat GAPDH leukin-1 and interleukin-6 and growth factors transform-(C), respectively. The sizes of mRNAs are indicated on the right side
of the picture. ing growth factor-b, epidermal growth factor (EGF),
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Fig. 8. Stimulation of c-met gene expression by cytokines and growth
factors in cultured renal epithelial cells. Mouse mIMCD-3 cells were
incubated for 24 hours in serum-free medium without (control) or with
specific cytokines or growth factors at a concentration of 10 ng/ml. Total
cellular RNA was isolated and hybridized using rat c-met cDNA as a
probe. The same blot was stripped and reprobed with GAPDH to confirm
equal loading of the RNA. Similar results were obtained using proximal
tubule-derived opossum kidney epithelial cells (data not shown).
in opossum kidney proximal tubular epithelial cells (data
not shown). These results suggest that the c-met gene is
remarkably sensitive to cytokine stimulation in the distal
segments of the renal tubule, the site of greatest injury
and regeneration in the folic acid model [29], as well as
in the cells derived from the proximal tubule. Of interest
is the finding that HGF itself is one of the most potent
inducers of c-met expression. Given the fact that there
was a rapid and dramatic elevation of HGF protein in
the circulation beginning as early as 0.5 hours in the
rats injected by folic acid (Fig. 3), HGF might also be
responsible for increased c-met expression in vivo.
c-met induction occurs primarily at the
transcriptional level
The increase in c-met mRNA in renal epithelial cells
Fig. 7. HGF and c-met protein levels in nonrenal organs following
could result from either increased transcription or en-acute renal injury. (A) Tissue HGF protein levels. Lung, liver, and
spleen from control (h) or folic acid–treated ( , 6 hr; j, 24 hr) rats hanced mRNA stability. To examine this issue, we mea-
were homogenized in HGF extraction buffer. HGF levels were deter- sured c-met mRNA abundance in mIMCD-3 cells fol-mined using an EIA kit specific for rat HGF. Data are mean 6 se of
lowing inhibition of transcription by actinomycin D. Asfour animals per group. *P , 0.05 versus control group. (B) Tissue
c-met receptor protein levels. Lung, liver, and spleen from control (h) shown in Figure 9, under normal conditions, HGF stimu-
or folic acid–treated ( , 6 hr; 24 hr) rats were pooled and homoge-
lated c-met expression in mIMCD-3 cells. However, pre-nized in RIPA lysis buffer. Tissue lysates were separated on a nonreduc-
ing SDS-polyacrylamide gel (50 mg/lane). Immunoblotting was per- treatment of the cells with actinomycin D for one hour
formed using a specific anti-c-met antibody. Quantitation of c-met totally blocked c-met induction (lanes 3 and 4), sug-protein levels was plotted after analyzing hybridized signals by densi-
gesting that HGF-induced c-met expression was com-tometer. Data are an average of the values from two experiments and
are expressed as arbitrary units. pletely dependent on gene transcription. In addition,
HGF did not stabilize c-met mRNA in mIMCD-3 cells,
as degradation of c-met mRNA was still evident in the
presence of HGF and the absence of transcription (com-insulin-like growth factor-I and -II (IGF-I, IGF-II),
pare lanes 6 and 2). Taken together, these data establishplatelet-derived growth factor, as well as HGF itself,
that c-met induction occurs primarily, if not entirely, atsignificantly induced c-met expression in mIMCD-3 cells
(Fig. 8). A similar pattern of responses was also observed the transcriptional level in renal epithelial cells.
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Fig. 9. Inhibition of transcription blocks c-met induction by HGF.
Mouse mIMCD-3 cells were either pretreated with 5 mg/ml actinomycin
D for one hour (lanes 3 and 4) or not pretreated (lanes 1, 2, 5, and 6).
Cultures were then treated with HGF (lanes 2 and 4) or without treat-
ment (lanes 1 and 3). To study the stability of c-met mRNA, some Fig. 10. HGF directly stimulates c-met promoter activity. Mouse
cultures were treated with HGF initially and were then treated with mIMCD-3 cells were transiently transfected with a 2.6 kb c-met pro-
actinomycin D for one hour prior to harvest (lanes 5 and 6). Total moter-CAT construct using the calcium phosphate coprecipitation
cellular RNA was isolated and hybridized using rat c-met cDNA. The method. After transfection, the cells were incubated for an additional
same blot was stripped and probed with GAPDH to confirm equal 24 hours in serum-free medium without (control) or with 10 ng/ml
loading of the RNA. recombinant rat HGF. Relative CAT was determined and normalized
for b-galactosidase activity. The results are presented as mean 6 se
from three separate experiments. P , 0.01 versus control.
HGF stimulates c-met promoter activity
To further investigate the mechanism of c-met tran-
nous infusion, studies in experimental models suggestscriptional regulation, we recently cloned and character-
that HGF action is specifically targeted to the damagedized the human c-met gene promoter region [39]. Tran-
organ. However, the mechanism of this important tar-sient transfection revealed that the 2.6 kb of the c-met
geting process remains to be elucidated. Based in partpromoter region (corresponding to nucleotide sequence
on the fact that the diverse biological functions of HGF
22615 , 160) directs c-met expression in renal epithe-
are mediated by a single functional receptor, we hypothe-lial mIMCD-3 cells [39]. To test whether HGF directly
sized that increased local expression of the c-met recep-stimulates c-met transcription, we transfected a c-met
tor might target HGF action precisely to the injuredpromoter-CAT reporter gene construct into cultured
organ. Consistent with this view, we found that expres-mIMCD-3 cells and exposed the transfected cells to rat
sion of both HGF and its c-met receptor increased rap-HGF in serum-free medium. As shown in Figure 10,
idly in kidneys that were acutely injured by administra-treatment of transfected cells with HGF dramatically
tion of folic acid. However, whereas there was clearincreased CAT activity by 4.5-fold as compared with
evidence for a systemic HGF response, induction ofcontrols (Fig. 10). These results demonstrate that the 2.6
c-met was closely correlated with the site of injury andkb c-met promoter region contains a cis-acting ele-
subsequent repair. This suggests that local induction ofment(s) responsive to HGF stimulation and further sup-
c-met expression is a critical factor determining the siteport the notion that HGF directly activates c-met gene
specificity of this receptor–ligand system.transcription in renal epithelial cells.
Although induction of c-met mRNA in the kidney
following acute injury has been previously reported [20,
DISCUSSION 21, 40], our study is the first to precisely quantitate
c-met receptor protein in renal epithelium and thereforeIt has been suggested that administration of exogenous
to demonstrate the marked degree of c-met stimulationHGF might be used to promote tissue regeneration in
that develops in this setting. Up-regulation of c-metthe liver and kidney following acute injury. One potential
mRNA could be an adaptive response serving only toconcern, suggested by the fact that c-met is a proto-
replace receptors that are destroyed by a process of ligand-oncogene, is that systemic administration of HGF might
induced endocytosis. However, the marked augmenta-be associated with undesirable phenotypic changes in
tion of c-met protein abundance we observed in thecells distant from the site of injury, including malignant
kidneys of folic acid rats suggests that increased c-mettransformation. Fortunately, regardless of whether HGF
levels are increased by endogenous production or exoge- gene expression not only replaces lost receptors, but
Liu et al: Induction of HGF receptor in ARF 451
also acts as an amplification pathway tending to increase of c-met in the damaged kidney is mediated by increased
availability of other cytokines or growth factors (Fig. 8)overall activity of the system and promote epithelial cell
proliferation and tubular repair. or that multiple factors acting in concert, including HGF
itself, may be necessary. Regardless of the mechanism,Although endogenous systemic HGF levels already
rise dramatically in experimental acute renal failure, once induced, increased availability of c-met receptor
should augment HGF action in a site-specific fashion.infusion of exogenous HGF further promotes renal epi-
thelial cell proliferation and accelerates recovery from The notion that site-specific up-regulation of c-met is
crucial for targeting HGF action is consistent with sev-ischemic or toxic injury in rats [14, 15]. Currently, the
explanation for this phenomenon is unknown. The site- eral recent observations [21, 40, 44–46]. For example,
Joannidis et al examined HGF and c-met expression inspecific induction of c-met receptor in the kidney ob-
served in this study provides a logical rationale for the the kidney and liver following renal ischemia or nephrec-
tomy [21]. They demonstrated that induction of HGFbeneficial effects of exogenous HGF. As the new synthe-
sized receptors are abundantly available, the rate-lim- mRNA occurred at sites distant to the injured organ
(liver), whereas c-met message increased selectively initing step probably is the supply of active HGF. In fact,
a significant decrease in HGF protein is observed in the the kidney and was maximal at the site of greatest renal
tubular injury or growth. Goto et al obtained similarkidney at 24 hours following injury (Fig. 4), a timing
concordant with marked elevation of renal c-met recep- results in the glycerol-induced model of acute renal fail-
ure [40]. In human liver disease, recent studies showtor protein (Fig. 5). This suggests that active renal con-
sumption may be the primary basis for the reduction that hepatocellular proliferation correlates with c-met
receptor level, but not with HGF abundance, suggestingof renal HGF protein, although the proposed injury-
associated release of extracellular matrix-bound HGF to that, for the liver as well, increased production of c-met
not only modulates the extent, but also determines thethe circulation could be another potential cause.
Previous morphologic and functional studies demon- site of cell proliferation and tissue regeneration [44, 45].
In HGF-transgenic mice, overproduction of HGF occursstrate that the medullary collecting duct epithelial cells
are the components of the kidney most susceptible to systemically, and c-met expression is also enhanced. Nev-
ertheless, it is the level of c-met protein in specific tissuesinjury and have the greatest degree of regeneration in
the folic acid model of nephropathy in vivo [29]. This in these mice that best correlates with the degree of cell
proliferation and tumorigenesis [46]. Collectively, all ofrationalizes the selection of mIMCD-3 cells, derived
from inner medullary collecting duct epithelium, as an these data indicate that a functional coupling exists be-
tween c-met receptor levels and biological actions of thisin vitro model system for investigating the factors regu-
lating c-met expression in renal epithelia. The finding signaling system in diverse tissues. Thus, it appears that
site-specific induction of c-met abundance is a generalthat marked activation of early response genes and
growth factors occurs in the kidney of the folic acid targeting mechanism for HGF action.
In contrast to the site-specific nature of c-met induc-model in vivo [37, 38] provides a molecular clue to iden-
tify the potential inducers for c-met expression. We tion, HGF expression is simultaneously induced in multi-
ple organs following local tissue injury. This pattern offound that c-met expression is enhanced by a variety of
cytokines and growth factors, including HGF (Fig. 8); systemic induction of HGF expression is not limited to
models of renal disease. For example, following hepatec-such an induction of c-met expression is primarily con-
trolled at the transcriptional level (Figs. 9 and 10). The tomy or CCl4 administration, HGF expression is in-
creased not only in the liver, but also in distant organs,potent ability of HGF to induce its own receptor coupled
with the early and rapid increase of HGF in vivo (Fig. including kidney, spleen, and lung [27, 47]. In a model
of myocardial ischemia and reperfusion in the rat, HGF4) suggests that HGF may itself be responsible, at least
in part, for c-met induction following injury. The reason mRNA was increased in the heart, kidney, liver, lung,
and spleen [48]. The biological significance of this phe-that HGF induces c-met in the injured kidney but not
in other intact organs in vivo is not fully understood. nomenon is not entirely understood; however, one obvi-
ous consequence is the provision of abundant HGF toOne potential explanation is suggested by the finding
that HGF is produced in vivo as an inactive, single-chain the injured organ. Of note, renal epithelial cells do not
express HGF under any conditions tested to date, and aprecursor requiring conversion to a heterodimeric, active
form by proteolytic processing. Thus, it has been sug- paracrine mechanism for HGF action has been assumed.
The marked increase in HGF production by distant or-gested that HGF in the circulation and normal tissues is
biologically inert and that specific activation of HGF gans and a consequent rise in circulating HGF levels
suggest that an endocrine-type pathway may significantlyoccurs only within the injured organ [35, 41, 42]. Several
serine proteases are believed to be responsible for acti- contribute to the injury response.
Several mechanisms have been proposed to explainvating HGF, and their activity is rapidly and exclusively
increased in the injured tissues in response to injurious the beneficial effects of HGF in acute renal failure. HGF
has mitogenic, motogenic, and morphogenic actions onstimuli [42, 43]. Alternatively, it may be that induction
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